Page last updated: 2024-09-04

l 741742 and cp 293019

l 741742 has been researched along with cp 293019 in 2 studies

Compound Research Comparison

Studies
(l 741742)
Trials
(l 741742)
Recent Studies (post-2010)
(l 741742)
Studies
(cp 293019)
Trials
(cp 293019)
Recent Studies (post-2010) (cp 293019)
1004901

Protein Interaction Comparison

ProteinTaxonomyl 741742 (IC50)cp 293019 (IC50)
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.15
5-hydroxytryptamine receptor 1AMus musculus (house mouse)0.18

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bristow, LJ; Hutson, PH; Rowley, M1
Hopkins, CR; Lindsley, CW1

Reviews

2 review(s) available for l 741742 and cp 293019

ArticleYear
Current and novel approaches to the drug treatment of schizophrenia.
    Journal of medicinal chemistry, 2001, Feb-15, Volume: 44, Issue:4

    Topics: Animals; Antipsychotic Agents; Cholinergic Agonists; Disease Models, Animal; Dopamine Antagonists; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Humans; Mice; Mice, Transgenic; Nitric Oxide Synthase; Receptor, Serotonin, 5-HT2A; Receptors, AMPA; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotensin; Receptors, Serotonin; Schizophrenia; Serotonin Antagonists

2001
Return of D
    Journal of medicinal chemistry, 2017, 09-14, Volume: 60, Issue:17

    Topics: Animals; Drug Discovery; Humans; Ligands; Molecular Targeted Therapy; Neoplasms; Parkinson Disease; Receptors, Dopamine D4; Small Molecule Libraries; Substance-Related Disorders

2017